30
/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
2307057
194118
2

jan 1, 2011 - HPTN 052 trial shows 96% reduced risk of onfection in serodiscordant couples. FDA approves Complera a second all-in- one combination tablet.

Added to timeline:

Date:

jan 1, 2011
Now
~ 13 years ago